Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosis

Springer Science and Business Media LLC - Tập 22 - Trang 1-12 - 2020
Emmanuel Ledoult1,2,3, David Launay1,2,3, Hélène Béhal4, Luc Mouthon5, Grégory Pugnet6, Jean-Christophe Lega7, Christian Agard8, Yannick Allanore9, Patrick Jego10, Anne-Laure Fauchais11, Jean-Robert Harlé12, Sabine Berthier13, Achille Aouba14, Arsène Mekinian15, Elisabeth Diot16, Marie-Elise Truchetet17, Carine Boulon18, Alain Duhamel4, Eric Hachulla1,2,3, Vincent Sobanski1,2,3
1Univ. Lille, Institute for Translational Research in Inflammation (INFINITE), Lille, France
2CHU Lille, Service de Médecine Interne, Centre de Référence des Maladies Auto-immunes et Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), Lille, France
3Inserm, U1286, Lille, France
4Univ. Lille, CHU Lille, EA 2694-Santé publique, épidémiologie et qualité des soins, Unité de Biostatistiques, Lille, France
5Hôpital Cochin–APHP, Service de Médecine Interne, Paris, France
6CHU Toulouse, Service de Médecine Interne, Toulouse, France
7CHU Lyon Sud, Service de Médecine Interne, Pierre-Bénite, France
8CHU Nantes, Service de Médecine Interne, Nantes, France
9Hôpital Cochin–APHP, Service de Rhumatologie, Paris, France
10CHU Rennes, Service de Médecine Interne, Rennes, France
11CHU Limoges, Service de Médecine Interne, Limoges, France
12Hôpital de la Timone, Service de Médecine Interne, Marseille, France
13CHU Dijon, Service de Médecine Interne et Immunologie Clinique, Dijon, France
14CHU Caen, Service de Médecine Interne, Caen, France
15Hôpital Saint-Antoine – APHP, Service de Médecine Interne, Paris, France
16CHU Tours, Service de Médecine Interne, Tours, France
17CHU Bordeaux, Service de Rhumatologie, Bordeaux, France
18CHU Bordeaux, Service de Médecine vasculaire, Bordeaux, France

Tóm tắt

Systemic sclerosis (SSc) is a severe and highly heterogeneous disease. The modified Rodnan skin score (mRSS) is a widely used tool for the assessment of the extent and degree of skin thickness. This study aimed to identify the classes of patients with early similar skin thickening trajectories without any a priori assumptions and study their associations with organ involvement and survival. From the French SSc national cohort, patients with a disease duration of less than 2 years at inclusion and with at least 2 mRSS available within the first 4 years of follow-up were enrolled. Classes of patients with similar mRSS trajectories were identified based on a latent class mixed model. The clinical characteristics and survival rate were compared between the obtained classes. A total of 198 patients fulfilled the inclusion criteria, with a total of 641 mRSS available. The median disease duration and follow-up were 0.8 (interquartile range 0.4; 1.2) and 6.3 (3.8; 8.9) years, respectively. Individual trajectories of mRSS were highly heterogeneous between patients. Models with 1–6 latent classes of trajectories were sequentially assessed, and the 5-class model represented the best fit to data. Each class was characterized by a unique global trajectory of mRSS. The median disease duration did not differ significantly between classes. Baseline organ involvement was more frequent in classes with significant change over time (classes 2–5) than in class 1 (low baseline mRSS without significant change over time). Using Cox regression, we observed a progressively increasing risk of death from classes 1 to 5. Early identification of clinical phenotype based on skin thickening trajectories could predict morbi-mortality in SSc. This study suggested that mRSS trajectories characterization might be pivotal for clinical practice and future trial designs.

Tài liệu tham khảo